CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,141,003 | -22.7% | 87,782 | 0.0% | 0.02% | -34.5% |
| Q4 2022 | $2,768,644 | +11.6% | 87,782 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $2,481,000 | -32.5% | 87,782 | -16.4% | 0.03% | -29.3% |
| Q1 2022 | $3,676,000 | -70.7% | 105,000 | -75.3% | 0.04% | -73.5% |
| Q3 2021 | $12,531,000 | -40.7% | 424,767 | -48.5% | 0.16% | -36.5% |
| Q2 2021 | $21,121,000 | +51.9% | 824,389 | -18.6% | 0.24% | +36.3% |
| Q1 2021 | $13,901,000 | -37.5% | 1,012,480 | -24.5% | 0.18% | -43.0% |
| Q4 2020 | $22,242,000 | – | 1,341,485 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |